INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.

Niklas GrasslKatharina SahmHeike SüßeIsabel PoschkeLukas BunseTheresa BunseTamara BoschertIris MildenbergerAnne-Kathleen RuppMax Philipp EwingerLisa-Marie LanzMonika DenkGhazaleh TabatabaiMichael W RonellenfitschUlrich HerrlingerMartin GlasDietmar KrexPeter VajkoczyAntje WickInga HartingFelix SahmAndreas von DeimlingMartin BendszusWolfgang WickMichael Platten

Published in: Neurological research and practice (2023)

NCT04808245.

Keyphrases

high grade
clinical trial
study protocol
low grade
phase ii
replacement therapy
smoking cessation